Posts by Sandra Ansanay-Alex
The Swiss HealthTech Center in Biel
Thanks to its location, diverse culture, extensive experience and infrastructure, Switzerland Innovation Park Biel/Bienne (SIPBB) is the perfect platform to support startups in their early stages of development, as well as companies already well established in the market. Developing health related technologies is one of the key competencies of the Swiss HealthTech Center. …
Read More4 life sciences projects supported by the FIF
Four Geneva-based technology projects have won funding from the Fongit Innovation Fund (FIF) for their innovations. A seed loan of CHF 100,000 has been granted to Carrat Sàrl. Three grants of CHF 50,000 have been awarded to each of the following: iSleep, LaxiPed and Pneumoscope. Seed loan of CHF 100,000 awarded to Carrat…
Read MoreASPIVIX receives CE Mark approval for Carevix™
ASPIVIX, announced that carevix™, its novel Cervical Stabilizer, has attained CE marking. This next generation medtech device for routine procedures in gynecology will allow millions of women across Europe access to significantly less painful treatments and IUD insertions. Carevix™ is a cervical stabilizer that uses a gentle approach to minimize pain and bleeding…
Read MoreAlzheimer Research: Gliapharm raises CHF 3.65 Million
The Alzheimer’s Drug Discovery Foundation (ADDF) invests CHF 3.64 Million in GliaPharm to advance its lead programme to accelerate the development of GliaPharm’s new drug, with the aim to gain approval for clinical testing in Alzheimer’s disease. GliaPharm SA, a biotech company that specializes in the research and development of novel therapies to…
Read MoreAesyra raises CHF 2.6 Million
The Vaud-based and EPFL spin-off develops oral appliances preventing sleep bruxism and sleep apnea. The seed financing round was led by Supermoon Capital (USA), the world’s first fund focused on sleep technologies, and high-tech investor Creadd Ventures (Switzerland), with the participation of existing investor Zürcher Kantonalbank. The new financing will support the development…
Read MoreVandria Announces a CHF 18 Million Fundraising
The $20.6M (CHF 18M) round was led by ND Capital together with a small syndicate of HNW private investors. The Vaud-based start-up develops mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases Vandria was spun out of Amazentis SA in 2021 with backing by ND Capital to develop first-in-class small molecule mitophagy…
Read MoreWhat all life sciences start-ups should know about fundraising
The Biopôle campus in Lausanne brings together some of the world’s most innovative life sciences companies. But how does an organisation make the leap from ambitious start-up to major multinational? Here are some fundraising tips from Distalmotion and SEED Biosciences, established members of the Biopôle’s community. Focus on sales and revenue Many start-ups…
Read MoreHaleon awarded by the Prix Vaudois des Entreprises Internationales (PVEI)
Haleon, a former division of GSK that became independent in 2022, won the jury’s award in the “Foreign company” category. Haelon was born in July 2022 and is the new company resulting from the spin-off of the consumer healthcare branch of the pharmaceutical laboratory Glaxosmithkline (UK). The young company holds a portfolio of…
Read MoreA CHF 40,000 Grant from Venture Kick to Orio Therapeuthics
Orio Therapeutics has won a CHF 40,000 Venture Kick prize, alongside KIDEMIS and Rheo, with a project designed to reduce drug use, costs and side effects, while improving therapeutic outcomes. Orio Therapeutics is based on a patented technology developed by the two co-founders, Dr. Ziad Julier and Prof. Mikaël Martino, both EPFL alumni…
Read MoreDr. Madiha Derouazi becomes AC Immune’s CSO
Dr. Madiha Derouazi is the founder of the Swiss biotech AMAL Therapeutics and the former CEO of German-based company Speransa Therapeutics. She is an internationally well-known and recognised immunologist, entrepreneur, and vaccine developer. Her experience will help AC Immune become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease. AC…
Read More